Get the Stockscreener App
25.99
3.74%
-1.01
Liquidia Corp stock is traded at $25.99, with a volume of 2.20M.
It is down -3.74% in the last 24 hours and up +7.84% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$27.00
Open:
$26.83
24h Volume:
2.20M
Relative Volume:
0.82
Market Cap:
$2.24B
Revenue:
$17.49M
Net Income/Loss:
$-78.50M
P/E Ratio:
-21.66
EPS:
-1.2
Net Cash Flow:
$-52.85M
1W Performance:
-9.91%
1M Performance:
+7.84%
6M Performance:
+79.24%
1Y Performance:
+167.39%
1-Day Range:
$25.64
$27.14
1-Week Range:
$25.64
$28.89
52-Week Range:
$9.68
$29.94
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Industry
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
25.99 | 2.35B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium - The Manila Times
Liquidia Corporation to Present New Data on LIQ861 at Pulmonary Hypertension Professional Association Symposium - Quiver Quantitative
Boothbay Fund Management LLC Boosts Holdings in Liquidia Technologies, Inc. $LQDA - MarketBeat
Jefferies Highlights Yutrepia’s Market Edge in Supporting a Buy on Liquidia (LQDA) - MSN
Liquidia Corporation Breakout Confirmed by Volume MetricsJuly 2025 Retail & Daily Volume Surge Signals - beatles.ru
Liquidia Technologies Target of Unusually Large Options Trading (NASDAQ:LQDA) - MarketBeat
Liquidia Technologies (NASDAQ:LQDA) Sets New 1-Year HighHere's Why - MarketBeat
Vestal Point Capital LP Cuts Stake in Liquidia Technologies, Inc. $LQDA - MarketBeat
Full technical analysis of Liquidia Corporation stock2025 Price Targets & Low Risk Entry Point Tips - Newser
Heatmap analysis for Liquidia Corporation and competitorsPortfolio Profit Report & Real-Time Buy Zone Alerts - Newser
Is Liquidia Corporation attractive at current valuationJuly 2025 Setups & Advanced Technical Signal Analysis - خودرو بانک
Does Liquidia Corporation have a competitive edge2025 Market Outlook & Accurate Buy Signal Notifications - خودرو بانک
Liquidia Corp director Singh sells $220k in shares By Investing.com - Investing.com Canada
Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It - MSN
Liquidia Corp director Singh sells $220k in shares - Investing.com India
What the charts say about Liquidia Corporation todayJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Real time social sentiment graph for Liquidia CorporationMarket Risk Summary & Fast Gain Swing Alerts - Newser
Trend analysis for Liquidia Corporation this week2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Will Liquidia Corporation stock recover after recent drop2025 Market WrapUp & Fast Momentum Stock Entry Tips - Newser
Using economic indicators to assess Liquidia Corporation potentialPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - Newser
Intraday pattern recognizer results for Liquidia CorporationWeekly Profit Recap & Fast Moving Stock Trade Plans - Newser
Using data filters to optimize entry into Liquidia Corporation2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
Strategies to average down on Liquidia CorporationJuly 2025 Weekly Recap & Weekly High Potential Alerts - Newser
Will Liquidia Corporation benefit from macro trendsJuly 2025 Fed Impact & Community Consensus Picks - Newser
Liquidia at Wells Fargo Conference: Strategic Insights on Eutrebia Launch - Investing.com
Liquidia Unusual Options Activity - AInvest
Is Liquidia Corporation a speculative investment2025 Analyst Calls & Technical Pattern Based Signals - خودرو بانک
Using flow based indicators on Liquidia Corporation2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
Is Liquidia Corporation affected by consumer sentimentJuly 2025 Highlights & Weekly Breakout Stock Alerts - خودرو بانک
Manning of Liquidia sells $18.9 million in LQDA stock - Investing.com
Manning of Liquidia sells $18.9 million in LQDA stock By Investing.com - Investing.com UK
Why United Just Catapulted 39%, Pulling Two Rivals With It - Investor's Business Daily
Does Liquidia Corporation have a sustainable dividendQuarterly Trade Review & Low Drawdown Investment Ideas - خودرو بانک
Quantitative breakdown of Liquidia Corporation recent moveQuarterly Risk Review & Weekly Market Pulse Alerts - Newser
Analyzing Liquidia Corporation with risk reward ratio chartsQuarterly Trade Summary & Verified Short-Term Plans - Newser
Sector ETF performance correlation with Liquidia CorporationEarnings Recap Report & Low Risk Entry Point Tips - Newser
Measuring Liquidia Corporation’s beta against major indicesNew Guidance & High Accuracy Trade Signal Alerts - Newser
BTIG Raises Price Target for Liquidia (LQDA), Keeps Buy Rating - Insider Monkey
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):